The effect of syncope on brain natriuretic peptide

Matthew J. Reed*, Louise Gibson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Background: Brain natriuretic peptide (BNP) may be a good prognostic marker in syncope. The aim of this study was to establish whether there is any change in BNP in association with an acute presentation. Methods: Patients aged ≥60 years admitted following presentation to the emergency department (ED) with syncope were eligible for prospective enrolment. Serial BNP measurements were performed on admission and at intervals up to 4 weeks after presentation. Results: Between 8 March 2010 and 14 April 2010, 31 patients were recruited and were suitable for analysis, including seven patients who returned to the ED at 4 weeks. Mean BNP rose from a baseline of 167.8 ng/ml to a peak of 303.2 ng/ml at 48 h and then returned to baseline at 4 weeks. BNP ratio reached 2.3 (more than twice admission level) at 18 h and peaked at 2.4 at 1 week before returning to baseline at 4 weeks. Conclusions: BNP seems to rise from baseline to a peak between 18 h and 1 week after an acute syncopal episode in many patients. The reasons for this are not clear.

Original languageEnglish
Pages (from-to)1066-1067
Number of pages2
JournalEmergency Medicine Journal
Issue number12
Publication statusPublished - Dec 2011

Fingerprint Dive into the research topics of 'The effect of syncope on brain natriuretic peptide'. Together they form a unique fingerprint.

Cite this